I-Mab ADR (IMAB)
Today's Latest Price: $49.52 USD
Updated Jan 15 4:00pm
Add IMAB to WatchlistSign Up
POWR Components:
Trade Grade Buy & Hold Grade Peer Grade Industry Rank
Industry Rank:
Ranked of 239 in Medical - Pharmaceuticals
See all "A" rated Strong Buy stocks
I-Mab (IMAB) Price Targets From Analysts
The tables below show the price targets and recommendations analysts covering IMAB.
| Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Current Price | Upside Potential |
|---|---|---|---|---|---|
| 6 | $58.09 | $51.03 | $54.32 | $49.76 | 9.16% |
IMAB Broker Recommendations Summary
| Average Broker Rating | Strong Buy | Buy | Hold | Sell | Strong Sell | Analysts Issuing Recs |
|---|
The bullet points below may help you gain a better understanding of what the metrics in the price target and recommendations tables above mean for IMAB as an investment opportunity.
- The average analyst price target of IMAB is greater than 95.16% of stocks in the micro market cap category.
- IMAB has a greater number of analysts covering the stock than 94.29% of stocks in the micro market cap category.
- The variance in analysts' estimates of IMAB is lower than 83.38% of Pharmaceutical Products stocks.
- The upside potential (average analyst target price relative to current price) of IMAB is greater than 21.95% of Pharmaceutical Products stocks.
- I-Mab's percent of analysts bearish on the stock is lower than almost 100% of all US stocks.
- IMAB has a greater percentage of analysts bullish on the stock than nearly none of all US stocks.
- The change in bullishness amongst analysts of IMAB is less than almost 100% of all US stocks.
Is IMAB a Buy, Hold or Sell? See the POWR Ratings now!